E
Evgeny Belilovski
Publications - 6
Citations - 800
Evgeny Belilovski is an academic researcher. The author has contributed to research in topics: Bedaquiline & Delamanid. The author has an hindex of 5, co-authored 6 publications receiving 471 citations.
Papers
More filters
Journal ArticleDOI
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Marina Tadolini,Luigi Codecasa,José-María García-García,François-Xavier Blanc,Sergey Borisov,Jan-Willem C. Alffenaar,Jan-Willem C. Alffenaar,Claire Andrejak,Pierre Bachez,Pierre-Alexandre Bart,Evgeny Belilovski,José Cardoso-Landivar,Rosella Centis,Lia D'Ambrosio,Maria Luiza de Souza-Galvão,Ángel Domínguez-Castellano,Samir Dourmane,Mathilde Fréchet Jachym,Antoine Froissart,Vania Giacomet,Delia Goletti,Soazic Grard,Gina Gualano,Armine Izadifar,Damien Le Dû,Margarita Marín Royo,Jesica Mazza-Stalder,Ilaria Motta,Catherine W.M. Ong,Fabrizio Palmieri,Frédéric Rivière,Teresa Rodrigo,Denise Rossato Silva,Adrián Sánchez-Montalvá,Matteo Saporiti,Paolo Scarpellini,Frédéric Schlemmer,Antonio Spanevello,Elena Sumarokova,Eva Tabernero,Paul A. Tambyah,Simon Tiberi,Simon Tiberi,Alessandro Torre,Dina Visca,Miguel Zabaleta Murguiondo,Giovanni Sotgiu,Giovanni Battista Migliori +47 more
TL;DR: Diagnostic, treatment and outcome details of 49 COVID-19 patients with concurrent or previous tuberculosis from 8 countries show varied clinical profiles.
Journal ArticleDOI
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey Borisov,Keertan Dheda,Martin Enwerem,Rodolfo Romero Leyet,Lia D'Ambrosio,Rosella Centis,Giovanni Sotgiu,Simon Tiberi,Simon Tiberi,Jan-Willem C. Alffenaar,Andrey Maryandyshev,Evgeny Belilovski,Shashank Ganatra,Alena Skrahina,Onno W. Akkerman,Alena Aleksa,Rohit Amale,Janina Artsukevich,Judith Bruchfeld,Jose A. Caminero,Isabel Carpena Martinez,Luigi Codecasa,Margareth Pretti Dalcolmo,Justin T Denholm,Paul Douglas,Raquel Duarte,Aliasgar Esmail,Mohammed Fadul,Alexey Filippov,Lina Davies Forsman,Mina Gaga,Julia Amaranta Garcia-Fuertes,José-María García-García,Gina Gualano,Jerker Jonsson,Heinke Kunst,Jillian S.Y. Lau,Barbara Lazaro Mastrapa,Jorge Lazaro Teran Troya,Selene Manga,Katerina Manika,Pablo González Montaner,Jai B Mullerpattan,Suzette Oelofse,Martina Ortelli,Domingo Palmero,Fabrizio Palmieri,Antonella Papalia,Apostolos Papavasileiou,Marie-Christine Payen,Emanuele Pontali,Carlos Robalo Cordeiro,Laura Saderi,Tsetan Dorji Sadutshang,Tatsiana Sanukevich,Varvara Solodovnikova,Antonio Spanevello,Sonam Topgyal,Federica Toscanini,Adrian R Tramontana,Zarir F Udwadia,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +64 more
TL;DR: Bedaquiline-containing regimens achieved high conversion and success rates under different nonexperimental conditions, and is safe and effective in treating MDR- and XDR-TB patients.
Journal ArticleDOI
MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
Giovanni Battista Migliori,Simon Tiberi,Simon Tiberi,Alimuddin Zumla,Eskild Petersen,Jeremiah Chakaya,Jeremiah Chakaya,Christian Wejse,Marcela Muñoz Torrico,Raquel Duarte,Jan-Willem C. Alffenaar,Jan-Willem C. Alffenaar,Jan-Willem C. Alffenaar,H. Simon Schaaf,Ben J. Marais,Daniela Maria Cirillo,Riccardo Alagna,Adrian Rendon,Emanuele Pontali,Alberto Piubello,Jose Figueroa,Gabriella Ferlazzo,Alberto L. García-Basteiro,Alberto L. García-Basteiro,Rosella Centis,Dina Visca,Lia D'Ambrosio,Giovanni Sotgiu,T. Abu Arkub,Onno W. Akkerman,Alena Aleksa,Evgeny Belilovski,Enrique Bernal,F-X. Blanc,Martin J. Boeree,Sergey Borisov,Judith Bruchfeld,J. Cadiñanos Loidi,Jose A. Caminero,Anna Cristina Calçada Carvalho,J.J. Cebrian Gallardo,Charalampos,Edvardas Danila,L. Davies Forsman,Justin T Denholm,Keertan Dheda,Roland Diel,Saulius Diktanas,Claudia C. Dobler,Martin Enwerem,Susanna Esposito,N. Escobar Salinas,Alex Filippov,B. Formenti,J.M. García García,Delia Goletti,R. Gomez Rosso,Gina Gualano,Petros Isaakidis,Anna Kaluzhenina,S. Koirala,Liga Kuksa,Heinke Kunst,Yang Li,Cecile Magis-Escurra,Vinicio Manfrin,Selene Manga,Katerina Manika,Valentina Marchese,E. Martínez Robles,Andrey Maryandyshev,Alberto Matteelli,Alessandro Wasum Mariani,Jesica Mazza-Stalder,Fernanda Carvalho de Queiroz Mello,L. Mendoza,A. Mesi,Skaidrius Miliauskas,H. Mustafa Hamdan,Norbert Ndjeka,M. Nieto Marcos,Tom H. M. Ottenhoff,Domingo Palmero,Fabrizio Palmieri,Apostolos Papavasileiou,Marie-Christine Payen,Agostina Pontarelli,M. Pretti Dalcolmo,S. Quirós Fernandez,R. Romero,D. Rossato Silva,A.P. Santos,Barbara Seaworth,M. Sinitsyn,Alena Skrahina,Ivan Solovic,Antonio Spanevello,Marina Tadolini,C. Torres,Zarir F Udwadia,M. van den Boom,Grigory V. Volchenkov,Askar Yedilbayev,R. Zaleskis,Jean-Pierre Zellweger +104 more
TL;DR: The review comprehensively describes the latest information on contact tracing and LTBI management in MDR-TB contacts, while providing guidance on post-treatment functional evaluation and rehabilitation of TB sequelae, infection control and other public health priorities.
Journal ArticleDOI
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Sergey Borisov,Edvardas Danila,Andrei Maryandyshev,Margareth Pretti Dalcolmo,Skaidrius Miliauskas,Liga Kuksa,Selene Manga,Alena Skrahina,Saulius Diktanas,Luigi Codecasa,Alena Aleksa,Judith Bruchfeld,Judith Bruchfeld,Antoniya Koleva,Alberto Piubello,Zarir F Udwadia,Onno W. Akkerman,Evgeny Belilovski,Enrique Bernal,Martin J. Boeree,Julen Cadiñanos Loidi,Qingshan Cai,Jose Joaquin Cebrian Gallardo,Masoud Dara,Edita Davidavičienė,Lina Davies Forsman,Lina Davies Forsman,Jorge De Los Rios,Justin T Denholm,Jacinta Drakšienė,Raquel Duarte,Seifeldin Eltaeb Elamin,Nadia Escobar Salinas,Maurizio Ferrarese,Alexey Filippov,Ana Garcia,José-María García-García,Ieva Gaudiesiute,Blagovesta Gavazova,Regina Gayoso,R. Rosso,Vygantas Gruslys,Gina Gualano,Wouter Hoefsloot,Jerker Jonsson,Elena Khimova,Heinke Kunst,Rafael Laniado-Laborín,Yang Li,Cecile Magis-Escurra,Vinicio Manfrin,Valentina Marchese,Elena Martínez Robles,Alberto Matteelli,Jesica Mazza-Stalder,Charalampos Moschos,Marcela Muñoz-Torrico,Hamdan Mustafa Hamdan,Birutė Nakčerienė,Laurent P. Nicod,Magnolia Nieto Marcos,Domingo Palmero,Fabrizio Palmieri,Apostolos Papavasileiou,Marie-Christine Payen,Agostina Pontarelli,Sarai Quirós,Adrian Rendon,Laura Saderi,Agnese Šmite,Ivan Solovic,Mahamadou Bassirou Souleymane,Marina Tadolini,Martin van den Boom,Marisa Vescovo,Pietro Viggiani,Askar Yedilbayev,Rolandas Zablockis,Dmitry Zhurkin,Matteo Zignol,Dina Visca,Antonio Spanevello,Jose A. Caminero,Jan-Willem C. Alffenaar,Simon Tiberi,Simon Tiberi,Rosella Centis,Lia D'Ambrosio,Emanuele Pontali,Giovanni Sotgiu,Giovanni Battista Migliori +90 more
TL;DR: This global project (658 patients from 26 countries) demonstrates aDSM is feasible and serious adverse events of recommended drugs are reasonably low (overall 57 out of 504, 11.3%), but implementation needs scaling up to support patient-centred care.
Journal ArticleDOI
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
Onno W. Akkerman,Alena Aleksa,Jan-Willem C. Alffenaar,Nada Hassan Al-Marzouqi,Miguel Arias-Guillén,Evgeny Belilovski,Enrique Bernal,Martin J. Boeree,Sergey Borisov,Judith Bruchfeld,Julen Cadiñanos Loidi,Qingshan Cai,Jose A. Caminero,Jose Joaquin Cebrian Gallardo,Rosella Centis,Luigi Codecasa,Lia D'Ambrosio,Margareth Pretti Dalcolmo,Edvardas Danila,Masoud Dara,Edita Davidavičienė,Lina Davies Forsman,Jorge De Los Rios Jefe,Justin T Denholm,Raquel Duarte,Seifeldin Eltaeb Elamin,Maurizio Ferrarese,Alexey Filippov,Shashank Ganatra,Ana Garcia,José-María García-García,Regina Gayoso,Ángela María Giraldo Montoya,R. Rosso,Gina Gualano,Wouter Hoefsloot,Biljana Ilievska-Poposka,Jerker Jonsson,Elena Khimova,Liga Kuksa,Heinke Kunst,Rafael Laniado-Laborín,Yang Li,Cecile Magis-Escurra,Vinicio Manfrin,Selene Manga,Valentina Marchese,Elena Martínez Robles,Andrei Maryandyshev,Alberto Matteelli,Giovanni Battista Migliori,Jai B Mullerpattan,Marcela Muñoz-Torrico,Hamdan Mustafa Hamdan,Magnolia Nieto Marcos,Noorliza Mohamad Noordin,Domingo Palmero,Fabrizio Palmieri,Marie-Christine Payen,Alberto Piubello,Emanuele Pontali,Agostina Pontarelli,Sarai Quirós,Adrian Rendon,Alena Skrahina,Agnese Šmite,Ivan Solovic,Giovanni Sotgiu,Mahamadou Bassirou Souleymane,Antonio Spanevello,Maja Stošić,Marina Tadolini,Simon Tiberi,Zarir F Udwadia,Martin van den Boom,Marisa Vescovo,Pietro Viggiani,Dina Visca,Dmitry Zhurkin,Matteo Zignol,adverse events monitoring +80 more
TL;DR: The aim of the a DSM project is to demonstrate the feasibility of implementing national aDSM registers and to describe the type and the frequency of adverse events (AEs) associated with exposure to the new anti-TB drugs.